Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 48

1.

SPARC Promotes Cell Invasion In Vivo by Decreasing Type IV Collagen Levels in the Basement Membrane.

Morrissey MA, Jayadev R, Miley GR, Blebea CA, Chi Q, Ihara S, Sherwood DR.

PLoS Genet. 2016 Feb 29;12(2):e1005905. doi: 10.1371/journal.pgen.1005905. eCollection 2016 Feb.

2.

E2f3 in tumor macrophages promotes lung metastasis.

Trikha P, Sharma N, Pena C, Reyes A, Pécot T, Khurshid S, Rawahneh M, Moffitt J, Stephens JA, Fernandez SA, Ostrowski MC, Leone G.

Oncogene. 2016 Jul 14;35(28):3636-46. doi: 10.1038/onc.2015.429. Epub 2015 Nov 9.

PMID:
26549026
3.

Peritumoral SPARC expression and patient outcome with resectable intrahepatic cholangiocarcinoma.

Cheng CT, Chu YY, Yeh CN, Huang SC, Chen MH, Wang SY, Tsai CY, Chiang KC, Chen YY, Ma MC, Liu CT, Chen TW, Yeh TS.

Onco Targets Ther. 2015 Jul 28;8:1899-907. doi: 10.2147/OTT.S78728. eCollection 2015.

4.

Non-Invasive In Vivo Imaging and Quantification of Tumor Growth and Metastasis in Rats Using Cells Expressing Far-Red Fluorescence Protein.

Christensen J, Vonwil D, Shastri VP.

PLoS One. 2015 Jul 17;10(7):e0132725. doi: 10.1371/journal.pone.0132725. eCollection 2015.

5.

SPARC mediates metastatic cooperation between CSC and non-CSC prostate cancer cell subpopulations.

Mateo F, Meca-Cortés O, Celià-Terrassa T, Fernández Y, Abasolo I, Sánchez-Cid L, Bermudo R, Sagasta A, Rodríguez-Carunchio L, Pons M, Cánovas V, Marín-Aguilera M, Mengual L, Alcaraz A, Schwartz S Jr, Mellado B, Aguilera KY, Brekken R, Fernández PL, Paciucci R, Thomson TM.

Mol Cancer. 2014 Oct 21;13:237. doi: 10.1186/1476-4598-13-237.

6.

Revisiting the matricellular concept.

Murphy-Ullrich JE, Sage EH.

Matrix Biol. 2014 Jul;37:1-14. doi: 10.1016/j.matbio.2014.07.005. Epub 2014 Jul 24. Review.

7.

Tumor-associated macrophages as incessant builders and destroyers of the cancer stroma.

Liguori M, Solinas G, Germano G, Mantovani A, Allavena P.

Cancers (Basel). 2011 Sep 28;3(4):3740-61. doi: 10.3390/cancers3043740.

8.

Downregulation of SPARC expression inhibits the invasion of human trophoblast cells in vitro.

Jiang Y, Zhu Y, Shi Y, He Y, Kuang Z, Sun Z, Wang J.

PLoS One. 2013 Jul 23;8(7):e69079. doi: 10.1371/journal.pone.0069079. Print 2013.

9.

Genes related to suppression of malignant phenotype induced by Maitake D-Fraction in breast cancer cells.

Alonso EN, Orozco M, Eloy Nieto A, Balogh GA.

J Med Food. 2013 Jul;16(7):602-17. doi: 10.1089/jmf.2012.0222.

10.

Matricellular proteins: priming the tumour microenvironment for cancer development and metastasis.

Wong GS, Rustgi AK.

Br J Cancer. 2013 Mar 5;108(4):755-61. doi: 10.1038/bjc.2012.592. Epub 2013 Jan 15. Review.

11.

Morphine and clonidine synergize to ameliorate low back pain in mice.

Tajerian M, Millecamps M, Stone LS.

Pain Res Treat. 2012;2012:150842. doi: 10.1155/2012/150842. Epub 2012 Apr 23.

12.

SPARC overexpression inhibits cell proliferation in neuroblastoma and is partly mediated by tumor suppressor protein PTEN and AKT.

Bhoopathi P, Gorantla B, Sailaja GS, Gondi CS, Gujrati M, Klopfenstein JD, Rao JS.

PLoS One. 2012;7(5):e36093. doi: 10.1371/journal.pone.0036093. Epub 2012 May 2.

13.

Blockade of SOX4 mediated DNA repair by SPARC enhances radioresponse in medulloblastoma.

Chetty C, Dontula R, Gujrati M, Dinh DH, Lakka SS.

Cancer Lett. 2012 Oct 28;323(2):188-98. doi: 10.1016/j.canlet.2012.04.014. Epub 2012 Apr 24.

14.

Losartan slows pancreatic tumor progression and extends survival of SPARC-null mice by abrogating aberrant TGFβ activation.

Arnold SA, Rivera LB, Carbon JG, Toombs JE, Chang CL, Bradshaw AD, Brekken RA.

PLoS One. 2012;7(2):e31384. doi: 10.1371/journal.pone.0031384. Epub 2012 Feb 14.

15.

Looking to the future: biomarkers in the management of pancreatic adenocarcinoma.

Spratlin JL, Mulder KE.

Int J Mol Sci. 2011;12(9):5895-907. doi: 10.3390/ijms12095895. Epub 2011 Sep 14. Review.

16.

DNA methylation of SPARC and chronic low back pain.

Tajerian M, Alvarado S, Millecamps M, Dashwood T, Anderson KM, Haglund L, Ouellet J, Szyf M, Stone LS.

Mol Pain. 2011 Aug 25;7:65. doi: 10.1186/1744-8069-7-65.

17.

Augmented osteolysis in SPARC-deficient mice with bone-residing prostate cancer.

McCabe NP, Kerr BA, Madajka M, Vasanji A, Byzova TV.

Neoplasia. 2011 Jan;13(1):31-9.

18.

A transcriptional map of the impact of endurance exercise training on skeletal muscle phenotype.

Keller P, Vollaard NB, Gustafsson T, Gallagher IJ, Sundberg CJ, Rankinen T, Britton SL, Bouchard C, Koch LG, Timmons JA.

J Appl Physiol (1985). 2011 Jan;110(1):46-59. doi: 10.1152/japplphysiol.00634.2010. Epub 2010 Oct 7.

19.

Behavioral signs of chronic back pain in the SPARC-null mouse.

Millecamps M, Tajerian M, Sage EH, Stone LS.

Spine (Phila Pa 1976). 2011 Jan 15;36(2):95-102. doi: 10.1097/BRS.0b013e3181cd9d75.

20.

Expression in SPARC-null mice of collagen type I lacking the globular domain of the α1(I) N-propeptide results in abdominal hernias and loss of dermal collagen.

Card L, Henderson N, Zhang Y, Bornstein P, Bradshaw AD.

Matrix Biol. 2010 Sep;29(7):559-64. doi: 10.1016/j.matbio.2010.08.002. Epub 2010 Aug 11.

Items per page

Supplemental Content

Write to the Help Desk